Case Study: Shape Therapeutics achieves AI-ready R&D data and faster gene therapy innovation with Benchling

Revolutionizing the field of gene therapy through the power of AI

Shape Therapeutics (ShapeTX) is a biotechnology company pioneering programmable RNA medicines, RNA editing, and next-generation gene therapy. As it scaled its R&D, the team needed Benchling to improve data traceability, eliminate silos, and create a central source of truth that could better connect wet-lab and dry-lab work.

Benchling implemented a phased rollout starting with its Notebook application, then added automated data capture and integrations to centralize experimental context, sample tracking, and results. The solution reduced manual work, improved data quality and lineage, and made data more AI-ready; ShapeTX also reported a 270% increase in use of pre-configured data-entry templates, helping scientists move faster and make interpretations more easily.

Shape Therapeutics

Ron Hause

Senior Vice President, Head of AI